Aska PharmaceuticalLtd. (4886.TSE) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
35
41
47
54

Details

Expected EPS
N/A
Actual EPS
35
Surprise EPS
35
Surprise Percent
+∞%

Description

Aska PharmaceuticalLtd. (4886.TSE) has reported earnings of 35 per share for Q2 2025.

0 Comments

Share your thoughts